Neuronetics (STIM) PT Lowered to $3 at Canaccord

March 18, 2026 9:03 AM

Canaccord analyst William Plovanic lowered the price target on Neuronetics (NASDAQ: STIM) to $3.00 (from $7.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found